Terms: = Lung cancer AND SPOP, TEF2, 8405, ENSG00000121067, O43791
11 results:
1. Overexpression of SERPINA3 suppresses tumor progression by modulating spop/NF‑κB in lung cancer.
Jin Y; Zhang Y; Huang A; Chen Y; Wang J; Liu N; Wang X; Gong Y; Wang W; Pan J
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37417362
[TBL] [Abstract] [Full Text] [Related]
2. HS3ST1 Promotes Non-Small-Cell lung cancer Progression by Targeting the spop/FADD/NF-
Ji X; Cheng K; Gao C; Xie H; Zhu R; Luo J
Biomed Res Int; 2022; 2022():5509346. PubMed ID: 35909476
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Features of lung-Recurrent Hormone-Sensitive Prostate cancer.
Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
[TBL] [Abstract] [Full Text] [Related]
4. Influencing factors of depressive symptoms in patients with malignant tumour.
Wang D; He N; Liu Y; Pang R; Dilixiati M; Wumaier A
J Int Med Res; 2021 Dec; 49(12):3000605211062450. PubMed ID: 34894827
[TBL] [Abstract] [Full Text] [Related]
5. The emerging role of spop protein in tumorigenesis and cancer therapy.
Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X
Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237
[TBL] [Abstract] [Full Text] [Related]
6. The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients.
Lin Q; Zhang H; Ding H; Qian J; Lizaso A; Lin J; Han-Zhang H; Xiang J; Li Y; Zhu H
J Transl Med; 2019 Aug; 17(1):298. PubMed ID: 31470866
[TBL] [Abstract] [Full Text] [Related]
7. MiR-520b promotes the progression of non-small cell lung cancer through activating Hedgehog pathway.
Liu X; Liu J; Zhang X; Tong Y; Gan X
J Cell Mol Med; 2019 Jan; 23(1):205-215. PubMed ID: 30407707
[TBL] [Abstract] [Full Text] [Related]
8. The E2F1-miR-520/372/373-spop Axis Modulates Progression of Renal Carcinoma.
Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
[TBL] [Abstract] [Full Text] [Related]
9. spop promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer.
Luo J; Chen B; Gao CX; Xie HK; Han CN; Zhou CC
Biochem Biophys Res Commun; 2018 Sep; 504(1):289-294. PubMed ID: 30190126
[TBL] [Abstract] [Full Text] [Related]
10. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
[TBL] [Abstract] [Full Text] [Related]
11. spop promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.
Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW
Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696
[TBL] [Abstract] [Full Text] [Related]
